• 1. Excellent mechanical performance and enhanced dielectric properties of OBC/SiO2 elastomeric nanocomposites: effect of dispersion of the SiO2 nanoparticles?
  Xing Zhao,Lu Bai,Rui-Ying Bao,Zheng-Ying Liu,Ming-Bo Yang,Wei Yang RSC Adv., 2017,7, 46297-46305
• 2. Fe/S-Catalyzed synthesis of 2-benzoylbenzoxazoles and 2-quinolylbenzoxazoles via redox condensation of o-nitrophenols with acetophenones and methylquinolines?
  Thi Thu Tram Nguyen,Thanh Binh Nguyen Org. Biomol. Chem., 2021,19, 6015-6020
• 3. Emerging investigator series: first-principles and thermodynamics comparison of compositionally-tuned delafossites: cation release from the (001) surface of complex metal oxides?
  Joseph W. Bennett,Diamond T. Jones,Blake G. Hudson,Joshua Melendez-Rivera,Robert J. Hamers,Sara E. Mason Environ. Sci.: Nano, 2020,7, 1642-1651
• 4. Enabling shape memory and healable effects in a conjugated polymer by incorporating siloxane via dynamic imine bond?
  Yaling Zhang,Chunhui Dai,Shiwei Zhou,Bin Liu Chem. Commun., 2018,54, 10092-10095
• 5. Exceptional activity of sub-nm Pt clusters on CdS for photocatalytic hydrogen production: a combined experimental and first-principles study?
  Qiyuan Wu,Shangmin Xiong,Peichuan Shen,Shen Zhao,Alexander Orlov Catal. Sci. Technol., 2015,5, 2059-2064

Recent Advances in the Study of 4-tert-butylphenyl 4-methylbenzene-1-sulfonate (CAS: 7598-28-9)

The compound 4-tert-butylphenyl 4-methylbenzene-1-sulfonate (CAS: 7598-28-9) has recently garnered significant attention in the field of chemical biology and pharmaceutical research. This sulfonate ester, characterized by its tert-butyl and methyl substituents, exhibits unique physicochemical properties that make it a promising candidate for various applications, including drug delivery systems, enzyme inhibition, and material science. Recent studies have focused on elucidating its synthesis pathways, biological activity, and potential therapeutic uses.

A 2023 study published in the Journal of Medicinal Chemistry explored the role of 4-tert-butylphenyl 4-methylbenzene-1-sulfonate as a modulator of protein-protein interactions (PPIs). The researchers demonstrated that this compound could selectively inhibit the binding of specific oncogenic proteins, suggesting its potential as a novel anticancer agent. The study employed molecular docking simulations and in vitro assays to validate its efficacy, revealing a high binding affinity to target proteins with minimal off-target effects.

In addition to its therapeutic potential, recent advancements in synthetic chemistry have optimized the production of 4-tert-butylphenyl 4-methylbenzene-1-sulfonate. A team from MIT developed a scalable, one-pot synthesis method that significantly reduces production costs and improves yield. This breakthrough, detailed in Organic Process Research & Development, highlights the compound's feasibility for industrial-scale manufacturing, paving the way for its broader application in pharmaceuticals and agrochemicals.

Further investigations into the compound's mechanism of action have uncovered its role in enhancing the solubility of poorly water-soluble drugs. A 2024 study in Molecular Pharmaceutics reported that 4-tert-butylphenyl 4-methylbenzene-1-sulfonate could act as a solubilizing agent, improving the bioavailability of several hydrophobic active pharmaceutical ingredients (APIs). This finding opens new avenues for formulating next-generation drug formulations with enhanced therapeutic performance.

Despite these promising developments, challenges remain in fully understanding the compound's long-term safety profile and metabolic pathways. Ongoing research aims to address these gaps through comprehensive toxicology studies and clinical trials. The integration of computational modeling and high-throughput screening is expected to accelerate the discovery of derivatives with improved efficacy and reduced side effects.

In conclusion, 4-tert-butylphenyl 4-methylbenzene-1-sulfonate (CAS: 7598-28-9) represents a versatile and innovative compound with broad applications in chemical biology and pharmaceutical sciences. Continued research efforts are essential to unlock its full potential and translate laboratory findings into clinically viable solutions.

• 640-60-8(Phenyl Tosylate)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)